Clinical trial
Retinal and Cognitive Dysfunction in Type 2 Diabetes: Unraveling the Common Pathways and Identification of Patients at Risk of Dementia
NCT04281186 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retinal and Cognitive Dysfunction in Type 2 Diabetes: Unraveling the Common Pathways and Identification of Patients at Risk of Dementia
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 16, 2020
- Completion date
- December 31, 2024
- Enrollment
- 510 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive dysfunction, microperimetry, retinal function